Key result
Bloodstream infections developed in 32.1% of adults on ECMO, prolonging ECMO support without raising hospital mortality.
Why the study?
Bloodstream infections are frequent complications during ECMO, yet contemporary data on their incidence, microbiological spectrum, antimicrobial exposure, and outcomes from Latin American ECMO programs remain limited.
Cohort (n=243)
No
Answers are grounded in this paper and cite their sources.
Bloodstream infections affect nearly one-third of adults on ECMO in this Colombian center—predominantly caused by Gram-negative bacilli with high carbapenem resistance—and significantly prolong mechanical support and hospital stays without reaching a statistically significant difference in hospital mortality.
Background Bloodstream infections (BSI) are frequent complications during extracorporeal membrane oxygenation (ECMO), yet contemporary data from Latin American ECMO programs remain limited. We aimed to characterize the incidence, clinical features, microbiological spectrum, antimicrobial exposure, and outcomes of BSIs among adults receiving ECMO at a tertiary referral center in Colombia. Methods We conducted a retrospective cohort study of adults receiving ECMO for more than 48 h at Fundación Clínica Shaio, Bogotá, between January 2021 and December 2024. Patients with BSIs before ECMO cannulation or incomplete clinical records were excluded. Clinical, ECMO-related, microbiological, antimicrobial exposure, and outcome data were collected. Patients with and without BSIs during ECMO were compared using appropriate parametric or nonparametric tests. Incidence rates were calculated using ECMO time at risk, and time to first BSI was evaluated using Kaplan–Meier analysis. Results Among 324 patients who received ECMO during the study period, 243 met the inclusion criteria, of whom 78 (32.1%) developed BSI. Compared with patients without BSI, those with infection had longer ECMO support (median, 18.23 vs. 9.40 days; p < 0.0001), mechanical ventilation (20.07 vs. 14.99 days; p < 0.0001), intensive care unit stay (37.27 vs. 21.31 days; p < 0.0001), and hospital stay (48 vs. 30 days; all p < 0.001). Red blood cell transfusion volume was also greater among patients with BSI. Overall antimicrobial use throughout ECMO support was higher in the BSI group (239.09 vs. 209.14 DOT/100 ECMO-days). Overall, 107 BSI episodes involving 119 microorganisms were identified. Gram-negative bacilli accounted for 43.7% of isolates, Gram-positive cocci for 41.2%, and fungi for 15.1%. Klebsiella pneumoniae was the most frequent Gram-negative pathogen, with 76.9% of isolates resistant to carbapenems. Staphylococcus epidermidis and Candida parapsilosis were the predominant Gram-positive and fungal pathogens, respectively. Hospital mortality was 35.9% among patients with BSI and 30.3% among those without infection ( p = 0.383). Conclusions BSIs affected approximately one-third of adults receiving ECMO and were associated with prolonged ECMO support, mechanical ventilation, ICU and hospital stays, greater transfusion requirements, and increased antimicrobial exposure. The predominance of Gram-negative bacilli and the high proportion of carbapenem-resistant K. pneumoniae highlight the importance of local microbiological surveillance and antimicrobial stewardship in ECMO programs. These findings provide relevant epidemiological data from a Latin American tertiary-care center and may inform infection-prevention and empirical antimicrobial strategies in this high-risk population.
No takes yet. Share an insight, caveat, or question.
Hernández et al. (2026) conducted a cohort in Bloodstream infections during extracorporeal membrane oxygenation (ECMO) (n=243). Bloodstream infection during ECMO vs. No bloodstream infection during ECMO was evaluated on Hospital mortality (p=0.383). Bloodstream infections developed in 32.1% of adults on ECMO, prolonging ECMO support without raising hospital mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: